XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
110 hedge funds and large institutions have $966M invested in Acceleron Pharma in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
31% more funds holding
Funds holding: 84 → 110 (+26)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
Holders
110
Holding in Top 10
6
Calls
$11.8M
Puts
$5.74M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$17M | |
| 3 | +$16.2M | |
| 4 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
+$13.2M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$11.9M |
Top Sellers
| 1 | -$9M | |
| 2 | -$8.7M | |
| 3 | -$5.84M | |
| 4 |
DVC
Deer VII & Co
Larchmont,
New York
|
-$5.29M |
| 5 |
PA
Perceptive Advisors
New York
|
-$4.96M |